These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35621631)

  • 1. Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice.
    Eekhoudt CR; Bortoluzzi T; Varghese SS; Cheung DYC; Christie S; Eastman S; Mittal I; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Jassal DS
    Curr Oncol; 2022 Apr; 29(5):2941-2953. PubMed ID: 35621631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.
    Asselin CY; Lam A; Cheung DYC; Eekhoudt CR; Zhu A; Mittal I; Mayba A; Solati Z; Edel A; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Pierce GN; Niraula S; Jassal DS
    J Nutr; 2020 Sep; 150(9):2353-2363. PubMed ID: 32510147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity.
    Akolkar G; Bhullar N; Bews H; Shaikh B; Premecz S; Bordun KA; Cheung DY; Goyal V; Sharma AK; Garber P; Singal PK; Jassal DS
    Cardiovasc Ultrasound; 2015 Apr; 13():18. PubMed ID: 25889218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction.
    Goyal V; Bews H; Cheung D; Premecz S; Mandal S; Shaikh B; Best R; Bhindi R; Chaudhary R; Ravandi A; Thliveris J; Singal PK; Niraula S; Jassal DS
    Can J Cardiol; 2016 Dec; 32(12):1513-1519. PubMed ID: 27650929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
    Guenancia C; Hachet O; Aboutabl M; Li N; Rigal E; Cottin Y; Rochette L; Vergely C
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):777-85. PubMed ID: 26914236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Flaxseed Compared to ACE Inhibition in Treating Anthracycline- and Trastuzumab-Induced Cardiotoxicity.
    Telles-Langdon SM; Arya V; Haasbeek PR; Cheung DYC; Eekhoudt CR; Mackic L; Bryson AN; Varghese SS; Austria JA; Thliveris JA; Aukema HM; Ravandi A; Singal PK; Jassal DS
    CJC Open; 2024 Jul; 6(7):925-937. PubMed ID: 39026621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
    Zeglinski M; Premecz S; Lerner J; Wtorek P; Dasilva M; Hasanally D; Chaudhary R; Sharma A; Thliveris J; Ravandi A; Singal PK; Jassal DS
    Can J Cardiol; 2014 Mar; 30(3):359-67. PubMed ID: 24484915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin and trastuzumab regimen induces biventricular failure in mice.
    Milano G; Raucci A; Scopece A; Daniele R; Guerrini U; Sironi L; Cardinale D; Capogrossi MC; Pompilio G
    J Am Soc Echocardiogr; 2014 May; 27(5):568-79. PubMed ID: 24534652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity.
    Walker JR; Sharma A; Lytwyn M; Bohonis S; Thliveris J; Singal PK; Jassal DS
    J Am Soc Echocardiogr; 2011 Jun; 24(6):699-705. PubMed ID: 21353471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity.
    Pituskin E; Mackey JR; Koshman S; Jassal D; Pitz M; Haykowsky MJ; Pagano JJ; Chow K; Thompson RB; Vos LJ; Ghosh S; Oudit GY; Ezekowitz JA; Paterson DI
    J Clin Oncol; 2017 Mar; 35(8):870-877. PubMed ID: 27893331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
    Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
    Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing broken hearts in women with breast cancer: a concise review on chemotherapy-mediated cardiotoxicity.
    Bews HJ; Mackic L; Jassal DS
    Can J Physiol Pharmacol; 2024 Sep; 102(9):487-497. PubMed ID: 38039515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.
    Saeed MF; Premecz S; Goyal V; Singal PK; Jassal DS
    Can J Physiol Pharmacol; 2014 Jul; 92(7):546-50. PubMed ID: 24959994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.
    Ebrahim N; Al Saihati HA; Mostafa O; Hassouna A; Abdulsamea S; Abd El Aziz M El Gebaly E; Abo-Rayah NH; Sabry D; El-Sherbiny M; Madboly AG; Hussien NI; Saadani REH; Ebrahim HA; Badr OAM; Elsherbiny NM; Salim RF
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab.
    Altomare C; Lodrini AM; Milano G; Biemmi V; Lazzarini E; Bolis S; Pernigoni N; Torre E; Arici M; Ferrandi M; Barile L; Rocchetti M; Vassalli G
    Front Physiol; 2021; 12():658790. PubMed ID: 33897465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-induced and trastuzumab-induced cardiotoxicity in mice is not prevented by metoprolol.
    Nicol M; Sadoune M; Polidano E; Launay JM; Samuel JL; Azibani F; Cohen-Solal A
    ESC Heart Fail; 2021 Apr; 8(2):928-937. PubMed ID: 33529501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity.
    Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W
    J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
    Lódi M; Bánhegyi V; Bódi B; Gyöngyösi A; Kovács Á; Árokszállási A; Hamdani N; Fagyas M; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
    J Transl Med; 2020 Dec; 18(1):470. PubMed ID: 33298102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of renin-angiotensin system antagonists in the prevention of bevacizumab- and sunitinib-mediated cardiac dysfunction.
    Mozolevska V; Schwartz A; Cheung D; Goyal V; Shaikh B; Dingman B; Kim E; Mittal I; Asselin CY; Edel A; Ravandi A; Thliveris J; Singal PK; Czaykowski P; Jassal DS
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H446-H458. PubMed ID: 30499710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin.
    Bishop S; Liu SJ
    Phytomedicine; 2017 Dec; 36():210-216. PubMed ID: 29157817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.